Cargando…
Anti-HMGCR Autoantibodies in European Patients With Autoimmune Necrotizing Myopathies: Inconstant Exposure to Statin
Necrotizing autoimmune myopathy (NAM) is a group of acquired myopathies characterized by prominent myofiber necrosis with little or no muscle inflammation. Recently, researchers identified autoantibodies (aAb) against 3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMGCR) in patients with NAM, espe...
Ejemplares similares
-
Exploring necrotizing autoimmune myopathies with a novel immunoassay for anti-3-hydroxy-3-methyl-glutaryl-CoA reductase autoantibodies
por: Drouot, Laurent, et al.
Publicado: (2014) -
Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti- Synthetase Auto-Antibodies: An Open-Label, Phase II Trial
por: Allenbach, Yves, et al.
Publicado: (2015) -
Prevention of Anti-HMGCR Immune-Mediated Necrotising Myopathy by C5 Complement Inhibition in a Humanised Mouse Model
por: Julien, Sarah, et al.
Publicado: (2022) -
Anti-HMGCR myopathy may resemble limb-girdle muscular dystrophy
por: Mohassel, Payam, et al.
Publicado: (2018) -
Diagnostic value of markers of muscle
degeneration in sporadic inclusion
body myositis
por: Dubourg, O., et al.
Publicado: (2011)